{"nct_id":"NCT07206056","title":"An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-11-28","start_date_type":"ESTIMATED","primary_completion_date":"2029-10-29","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12-17","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}